Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Unusual symptoms and syndromes in multiple sclerosis.
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Effects of Physical Exercise on Neuroinflammation, Neuroplasticity, Neurodegeneration, and Behavior: What We Can Learn From Animal Models in Clinical Settings.
[Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assays.
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Sexual disparities in the incidence and course of MS.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.
The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
The Mechanisms and Applications of T Cell Vaccination for Autoimmune Diseases: a Comprehensive Review.
Pages
« first
‹ previous
…
330
331
332
333
334
335
336
337
338
…
next ›
last »